Zephyr Health brings data analytics to life sciences, picks up $15M
Zephyr Health's Voyager application for viewing physician profiles. — Zephyr Health, the latest in a string of companies offering big data analytics to shake-up what has been a technology-resistant healthcare industry, has raised $15 million of venture funding.
Context & Ripple Effects
Zephyr Health is entering a sector its own backers describe as technology-resistant, selling Voyager physician profiles and analytics into life sciences rather than clinical care — a commercial-side wedge where data products face fewer regulatory barriers. The round drew unusually broad same-day pickup: on or about January 8, 2014 the story ran on TechCrunch, Gigaom, SiliconANGLE, PE Hub, bizjournals and three other outlets, a signal of how much attention the 'big data meets healthcare' thesis was attracting from investors and press alike.
First-order effects
- Zephyr Health gains $15 million to scale Voyager, giving life-sciences commercial teams physician-level profiling and analytics they previously lacked off-the-shelf tools for.
Second-order effects
- A funded template for physician-data analytics invites rivals and adjacent startups into the same buyer — pharmaceutical companies — pushing health systems and data holders toward treating physician information as a sellable asset.
Third-order effects
- If the pattern holds, healthcare's resistance to analytics erodes first on the commercial side: physician targeting hardens into standard pharma infrastructure and a recurring magnet for successive venture rounds.
The trend: Venture capital is moving into health-data analytics, opening with life-sciences commercial intelligence before reaching clinical care.